Overall rank by patents
#48,285
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, active 2017–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06T (IMAGE DATA PROCESSING OR GENERATION, IN GENERAL).
The verdict
Lavision holds 5 US patents across 7 technology areas, rank #48,285 of 50,000 tracked assignees.
Lavision Gmbh has been granted 5 US utility patents between 2017 and 2021, placing Lavision Gmbh at rank #48,285 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.4 claims per patent with primary concentration in G06T (IMAGE DATA PROCESSING OR GENERATION, IN GENERAL). As a Foreign Corporation, Lavision Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Lavision sits between Laser PEGS IP Holding Corp. (5 patents, rank #48,281) and Layar B.v. (5 patents, rank #48,289) - the closest US assignees by grant volume. The composite Innovation Score of 23.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 3 in the 2015–2019 window, a -33% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Lavision Gmbh's 13.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Lavision Gmbh against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
LASER PEGS IP HOLDING CORP.
5 patents
LASERGEN, INC.
5 patents
LAUNCHPOINT TECHNOLOGIES, INC.
5 patents
LAVA THERAPEUTICS N.V.
5 patents
LAWRENCE BERKELEY NATIONAL LABORATORY
5 patents
LAWTER, INC.
5 patents
LAXMI THERAPEUTIC DEVICES, INC.
5 patents
LAYAR B.V.
5 patents
LAVISION GMBH
5 patents
What this shows Lavision holds 5 patents at rank #48,285, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #48,285 in granted patent volume.
Other assignees with the most granted patents in Lavision's primary technology class.
Lavision's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
24 Top 88% higher than 12% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 40.0% |
| 2018 | 1 | 20.0% |
| 2021 | 2 | 40.0% |
Top 7 of 7 technology areas
Overall rank by patents
#48,285
Across all tracked assignees
23.6 out of 100
How to use this portfolio
Lavision's 5 grants land it in the top 88% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.